Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Arrowhead Research
ARWR
$12B
| $18.5M | 0.02% |
657,600
-131,200
| -17% | -$3.88M |
|
1002
Prudential Financial
PRU
$42.6B
| $18.5M | 0.02% |
205,900
-287,600
| -58% | -$26.1M |
|
1003
Voyager Therapeutics
VYGR
$184M
| $18.5M | 0.02% |
1,072,901
+343,100
| +47% | +$7.2M |
|
|
ONDK
1004
DELISTED
On Deck Capital, Inc.
ONDK
| $18.5M | 0.02% |
5,494,142
+111,167
| +2% | +$396K |
|
1005
AerCap
AER
$23.8B
| $18.5M | 0.02% |
337,096
+318,696
| +1,732% | +$16.8M |
|
1006
Huron Consulting
HURN
$2.42B
| $18.4M | 0.02% |
300,758
+51,400
| +21% | +$3M |
|
1007
Hackett Group
HCKT
$272M
| $18.4M | 0.02% |
1,120,330
+26,086
| +2% | +$429K |
|
1008
Nathan's Famous
NATH
$400M
| $18.4M | 0.02% |
256,500
+800
| +0.3% | +$56.8K |
|
1009
Renasant Corp
RNST
$3.96B
| $18.4M | 0.02% |
524,939
-14,500
| -3% | -$497K |
|
1010
Spok Holdings
SPOK
$223M
| $18.4M | 0.02% |
1,537,543
+30,559
| +2% | +$395K |
|
1011
Advanced Micro Devices
AMD
$795B
| $18.3M | 0.02% |
+631,795
| New | +$19.8M |
|
1012
Ethan Allen Interiors
ETD
$568M
| $18.3M | 0.02% |
958,700
+148,400
| +18% | +$2.82M |
|
|
WSR
1013
DELISTED
Whitestone REIT
WSR
| $18.2M | 0.02% |
1,323,989
+104,889
| +9% | +$1.35M |
|
1014
Eli Lilly
LLY
$1.02T
| $18.2M | 0.02% |
162,699
-2,145,902
| -93% | -$239M |
|
1015
State Street Financial Select Sector SPDR ETF
XLF
$56.9B
| $18.2M | 0.02% |
648,400
-1,013,300
| -61% | -$28M |
|
|
TRTX
1016
TPG RE Finance Trust
TRTX
$612M
| $18.1M | 0.02% |
913,946
+190,546
| +26% | +$3.76M |
|
1017
Atlantic Union Bankshares
AUB
$6.01B
| $18.1M | 0.02% |
486,502
-85,800
| -15% | -$3.14M |
|
1018
AutoNation
AN
$7.08B
| $18M | 0.02% |
355,600
+94,300
| +36% | +$4.44M |
|
|
CARO
1019
DELISTED
Carolina Financial Corp.
CARO
| $18M | 0.02% |
505,916
+4,100
| +0.8% | +$143K |
|
1020
First Commonwealth Financial
FCF
$2.16B
| $18M | 0.02% |
1,352,600
-50,600
| -4% | -$656K |
|
|
GLOG
1021
DELISTED
GASLOG LTD
GLOG
| $17.9M | 0.02% |
1,396,000
+83,500
| +6% | +$1.12M |
|
1022
TechTarget
TTGT
$322M
| $17.9M | 0.02% |
796,000
+89,600
| +13% | +$2.06M |
|
1023
Trade Desk
TTD
$8.44B
| $17.9M | 0.02% |
955,000
-949,000
| -50% | -$22.6M |
|
1024
Cohu
COHU
$2.29B
| $17.9M | 0.02% |
1,325,054
+336,800
| +34% | +$4.67M |
|
1025
Calix
CALX
$2.25B
| $17.9M | 0.02% |
2,798,918
-221,800
| -7% | -$1.4M |
|
Similar funds
Renaissance Technologies's Q3 2019 Portfolio in Review
As of Q3 2019, Renaissance Technologies held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Renaissance Technologies's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Renaissance Technologies added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Renaissance Technologies's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Renaissance Technologies fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Renaissance Technologies's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Renaissance Technologies opened 406 new positions and closed 522 in Q3 2019.
- Renaissance Technologies's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.